PCSK9 and myocardial ischemia: PCSK9 inhibitor pretreatment has also been shown to prevent brain injury caused by myocardial ischemia/reperfusion damage by reducing dendritic spine loss, attenuating microglial overactivation, and inhibiting Aβ aggregation (Apaijai et al., 2019).